Electro-mechanical effects of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212), a new positive inotropic agent. Isolated adult canine Purkinje strands and ventricular trabeculae
- PMID: 6540090
Electro-mechanical effects of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212), a new positive inotropic agent. Isolated adult canine Purkinje strands and ventricular trabeculae
Abstract
The electrical and mechanical effects of 3, 4-dihydro-6-[4-(3,4- dimethoxybenzoyl )-1-piperazinyl]-2(1H)- quin olinone ( OPC -8212), a new, non-glycosidic, positive inotropic agent, were examined in isolated adult canine purkinje strands and ventricular trabeculae. In isolated adult canine ventricular trabecular muscle, compound OPC -8212 increased force development in a concentration-dependent manner. OPC -8212 produced a concurrent increase in trabecular muscle transmembrane action potential durations measured at both 50% and 90% of repolarization. In isolated adult canine Purkinje strand preparations, compound OPC -8212 did not exhibit a positive inotropic effect. Compound OPC -8212 did, however, produce a concentration-dependent increase in Purkinje fiber transmembrane action potential durations that was proportionally greater than that observed in the trabecular muscle preparations. The effects of OPC -8212 on adult canine isolated Purkinje fiber and ventricular muscle electrical and mechanical characteristics are unlike those that have been reported for other drugs that increase myocardial inotropy; i.e. cardiac glycosides, catecholamines, amrinone, or phosphodiesterase inhibitors.
Similar articles
-
Mode and mechanism of action of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart.Arzneimittelforschung. 1984;34(3A):347-55. Arzneimittelforschung. 1984. PMID: 6331465
-
In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.Arzneimittelforschung. 1984;34(3A):342-6. Arzneimittelforschung. 1984. PMID: 6331464
-
Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure.Arzneimittelforschung. 1984;34(3A):390-3. Arzneimittelforschung. 1984. PMID: 6540094
-
The effect of a new positive inotropic agent, 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212), on thin bundles of skinned fibers from cardiac muscle.Arzneimittelforschung. 1984;34(3A):380-3. Arzneimittelforschung. 1984. PMID: 6540092
-
[Effects of catecholamines on myocardial action potentials and its relation with myocardial contractility].Nihon Rinsho. 1973 Sep;31(9):2678-86. Nihon Rinsho. 1973. PMID: 4588477 Review. Japanese. No abstract available.
Cited by
-
A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failure. OPC-8212 Multicenter Research Group.Cardiovasc Drugs Ther. 1990 Apr;4(2):419-25. doi: 10.1007/BF01857748. Cardiovasc Drugs Ther. 1990. PMID: 2285626 Clinical Trial.
-
Cyclic AMP-dependent and cyclic AMP-independent actions of a novel cardiotonic agent, OPC-8212.Naunyn Schmiedebergs Arch Pharmacol. 1988 Dec;338(6):692-8. doi: 10.1007/BF00165636. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 2854217
-
The inhibitory effects of a positive inotropic quinolinone derivative, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), on bone-marrow progenitor cells and peripheral lymphocytes.Eur J Clin Pharmacol. 1992;42(6):629-33. doi: 10.1007/BF00265927. Eur J Clin Pharmacol. 1992. PMID: 1623903
-
Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failure.Heart Vessels. 1986;2(1):23-8. doi: 10.1007/BF02060240. Heart Vessels. 1986. PMID: 3722083